Gut microbiota: impacts on gastrointestinal cancer immunotherapy.

ABSTRACT: The association of gut microbiota with gastrointestinal carcinogenesis has been heavily investigated since the recent advance in sequencing technology. Accumulating evidence has revealed the critical roles of commensal microbes in cancer progression. Given by its importance, emerging studies have focussed on targeting microbiota to ameliorate therapeutic effectiveness. It is now clear that the microbial community is closely related to the efficacy of chemotherapy, while the correlation of microbiota with immunotherapy is much less studied. Herein, we review the up-to-date findings on the influence of gut microbiota on three common immunotherapies including adoptive cell transfer, immune checkpoint blockade, and CpG-oligodeoxynucleotide therapy. We then explore three microbiota-targeted str

SUBMITTER: Lau HCH 

PROVIDER: S-EPMC7808428 | biostudies-literature | 2021 Jan-Dec

REPOSITORIES: biostudies-literature